entertainment -WSS

entertainment

author：leisure time 2025-10-01 22:49:27 - browse：2

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Why medical students are struggling with mental health

WSS

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

World's first CRISPR

Congress might make insulin pumps more accessible to the blind

David Sabatini, ex

Does good food count as health care? Study aims to find out

Why medical students are struggling with mental health

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

What does generative AI mean for health care? We asked experts

Morphosys mixed study results for blood cancer drug

Trump demands the U.S. pay no more for drugs than other countries … again

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Peter Hotez and the public health issue of online harassment

Hospitals look to new technology to keep health care workers safe

Duchenne breakthrough therapy leaves behind pioneering families

ACIP vaccine advisory panel sees its vacancies filled

Guidelines to prevent youth baseball injuries need more muscle

Why medical students are struggling with mental health

focus

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Why Eli Lilly’s earnings didn’t quite live up to the hype

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

FDA's Woodcock to retire early next year

AMAs digital advisors table RPM coding reform proposal, again

World's first CRISPR

entertainment

hotspot

explore

focus